A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2019
Price : $35 *
At a glance
- Drugs Ramipril (Primary) ; Temozolomide
- Indications Cognition disorders; Memory disorders
- Focus Therapeutic Use
- 08 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 1 Feb 2019.
- 29 Nov 2018 Planned initiation date changed from 1 Nov 2018 to 1 Dec 2018.
- 09 Nov 2018 Status changed from not yet recruiting to recruiting.